BlueDot, Toronto, Ontario, Canada.
BlueDot, Toronto, Ontario, Canada; Department of Mathematics and Statistics, York University, Toronto, Ontario, Canada.
J Infect Chemother. 2022 Nov;28(11):1519-1522. doi: 10.1016/j.jiac.2022.08.002. Epub 2022 Aug 9.
In Japan, as of December 31, 2021, more than 1.73 million laboratory-confirmed cases have been reported. However, the actual number of infections is likely to be under-ascertained due to the epidemiological characteristics such as mild and subclinical infections and limited testing availability in the early days of the pandemic. In this study, we infer the true number of infections in Japan between January 16, 2020, and December 31, 2021, using a statistical modelling framework that combines data on reported cases and fatalities.
We used reported COVID-19 deaths and age-specific infection fatality ratios (IFR) to impute the true number of infections. Estimates of IFR were informed from published studies and were adjusted to reflect the effects of pharmaceutical interventions, mass vaccination, and evolving variants. To account for the uncertainty in IFR, we sampled values from relevant distributions.
We estimated that as of December 31, 2021, 3.07 million (CrI: 2.05-4.24 million) people had been infected in Japan, which is 1.77 times higher than the 1.73 million reported cases. Our meta-analysis confirmed that these findings were consistent with the intermittent seroprevalence studies conducted in Japan.
We have estimated that a substantial number of COVID-19 infections in Japan were unreported, particularly in adults. Our approach provides a more realistic assessment of the true underlying burden of COVID-19. The results of this study can be used as fundamental components to strengthen population health control and surveillance measures.
截至 2021 年 12 月 31 日,日本报告了超过 173 万例实验室确诊病例。然而,由于疫情早期感染症状较轻和呈亚临床症状、检测能力有限等流行病学特征,实际感染人数可能被低估。本研究使用一种结合报告病例和死亡数据的统计建模框架,推断 2020 年 1 月 16 日至 2021 年 12 月 31 日期间日本的真实感染人数。
我们使用报告的 COVID-19 死亡病例和年龄特异性感染病死率(IFR)来推断真实感染人数。IFR 的估计值来源于已发表的研究,并进行了调整以反映药物干预、大规模疫苗接种和不断演变的变异体的影响。为了考虑 IFR 的不确定性,我们从相关分布中抽样取值。
我们估计截至 2021 年 12 月 31 日,日本已有 307 万人(95%置信区间:205 万至 424 万)感染,是报告病例数 173 万的 1.77 倍。我们的荟萃分析证实,这些发现与在日本进行的间歇性血清流行率研究结果一致。
我们估计日本有相当数量的 COVID-19 感染未被报告,尤其是在成年人中。我们的方法提供了对 COVID-19 真实潜在负担更现实的评估。本研究的结果可作为加强人群健康控制和监测措施的基本组成部分。